Colombia INVIMA registration INVIMA 2022RD-0007595

HEALGEN RAPID COVID-19 ANTIGEN SELF-TEST

Name: HEALGEN RAPID COVID-19 ANTIGEN SELF-TEST — Colombia INVIMA registration INVIMA 2022RD-0007595
Creator: DHM GLOBAL BUSINESS & TRADE SAS
Keywords: HEALGEN RAPID COVID-19 ANTIGEN SELF-TEST, INVIMA 2022RD-0007595, III, INVIMA registration

HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANYIIIColombia INVIMAExpires August 23, 2027

VerifiedINVIMA · official registry

Device classification

Registered product (Spanish): HEALGEN RAPID COVID-19 ANTIGEN SELF-TEST
Risk class / Clase de riesgo: III
Product group (Spanish): REACTIVO DIAGNOSTICO

Registration information

Sanitary registration: INVIMA 2022RD-0007595
Expediente: 20224132
Status / Estado: Active
Expiry date: August 23, 2027

Registration holder / Titular

Name: DHM GLOBAL BUSINESS & TRADE SAS

Associated party / Rol

Name: HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY
Role: FABRICANTE
Country: ESTADOS UNIDOS DE AMÉRICA
Manufacturer: HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY

About this record

Access comprehensive regulatory information for HEALGEN RAPID COVID-19 ANTIGEN SELF-TEST in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA sanitary registration INVIMA 2022RD-0007595, held by DHM GLOBAL BUSINESS & TRADE SAS and associated with HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY (FABRICANTE). The registration expires on August 23, 2027.

This page provides complete registration details including product group (REACTIVO DIAGNOSTICO), holder and associated-party information, and regulatory data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.